The factsheet has been successfully sent.
Please check your inbox.
Please fill in the form to receive the factsheet directly into your inbox
Submit
Cancel

0
You have items in your inquiry list.
Inquire now?

24 March 2021 [Press release]

Product Launch - GenoImmu COVID-19 Antigen Detection Kit

 

With the launch of the CE-IVD marked GenoImmuTM COVID-19 Antigen Detection Kit for rapid antigen testing, DiagCor Life Science extends its existing line of SARS-CoV-2-related products.

The kit is designed for the qualitative detection of novel coronavirus in various sample types. It is an immuno-chromatographic assay that applies the antigen-antibody binding specificity to detect nucleocapsid protein from SARS-CoV-2, and provides an aid in the diagnosis of infection with novel coronavirus.

● Rapid – Result in 15-30 minutes
● Multiple sample types – Single test strip, different accessories according to sample type
● Accurate – Sensitivity ≥ 95.1%, Specificity ≥ 99.0%
● User-friendly – Easy to use with a simple visualization result

Please see our product page or contact us directly for more details.

About DiagCor

Headquartered in Hong Kong, DiagCor has been dedicated solely to molecular diagnostics (MDx) since 2006. The global leader in flow-through hybridization technology, the company offers a range of products, solutions and services related to RNA and DNA analysis. As well as providing MDx laboratory services to Asia Pacific practitioners, Diagcor develops and manufactures MDx products and solutions, and offers MDx medical translation services and MDx consulting.



Press Contact

DiagCor Life Science

sales@diagcorlifescience.com